Our sponsors/exhibitors will offer seminars with the most recent technical and methodological advances in the field. Please see the information below.
MOST WELCOME!

Monday
12.00-12.40 Thermo Scientific

Tuesday
8.30-8.50 Bio-Rad Laboratories Ltd
8.30-8.50 Thermo Fisher

12.10-12.30/12.00-12.40
Vendor Seminar -Invitrogen Vendor Seminar -Waters

Wednesday
12.00-12.20 Applied Biosystems
12.00-12.20 EMBL-EBI


Monday:
Thermo Scientific Link to website: www.thermo.com/eupa2009
”Impact of a novel linear ion trap orbitrap instrument on high precision proteomics”
Prof. Matthias Mann, Max-Planck Institute for Biochemistry

Join us at our exciting lunch seminar event where Prof. Matthias Mann from the Max-Planck Institute for Biochemistry will talk about the ‘Impact of a novel linear ion trap-orbitrap instrument on high precision proteomics’. Find our more about the very latest developments in orbitrap and ion trap technology.

Tuesday:
Thermo Scientific Link to website: www.thermo.com/eupa2009
”Technology developments and productive approaches in omics.”
Dr. Madalina Oppermann, Thermo Fisher Scientific

Short seminar on novelties in metabolomics and proteomics applications, including updates from Thermo Fisher Scientific's participation at ASMS 2009.

Bio-Rad Laboratories Ltd Link to website: www.discover.bio-rad.com
”Combining combinatorial hexapeptide ligand fractionation and 2D-DIGE: Quantitative profiling of low abundant proteins” Dr. Stefan Lehr, German Diabetes Centre, Dusseldorf

Invitrogen
”Autoantibody biomarker profiling using the ProtoArray Human Protein Microarray”
Peter Kraus, Ph.D., Field Application Scientist, Invitrogen, part of Life Technologies

The diagnostic value of serum autoantibodies for many diseases, including cancer, diabetes, and autoimmune disorders, is well established. Realizing the promise of autoantibody panels in diagnosis, prognosis and treatment response predictions requires the use of multiplex tools that enable investigators to query the autoantibody profile on a proteomic scale. Identifying the antigens that elicit an autoimmune response can yield panels of biomarkers that can be used as classifiers for particular diseases, disease stages, or as predictors of patient outcomes. A high-content, functional human protein microarray has been developed as a biomarker discovery tool for identifying differential abundance of autoantibodies directed against over 9400 full-length native proteins. Several case studies detailing the use of this functional human protein microarray in the area of autoantibody biomarker discovery will be presented.

Waters Link to website:www.waters.com/waters/eventInstance.htm?eiid=10101662
"Introducing the New XevoTM MS Systems, Next Generation Technology for Proteomics"
Thérèse McKenna, Technical Manager, Proteomics, Waters Corporation

Wednesday:
Applied Biosystems (www.ebi.ac.uk/proteomics Link to the website www.appliedbiosystems.com
”Validating putative biomarkers - novel workflows and applications”
V. Kruft and C. Lenz

EMBL-EBI (Link to the website www.ebi.ac.uk/proteomics
"Paths through Proteomics - Proteomics and Pathway resources of the European Bioinformatics Institute"
Henning Hermjakob

The Proteomics Services Team at EBI provides databases and tools for the deposition, distribution and analysis of proteomics and proteomics-related data. We contribute to the development of community standards for proteomics data in the context of the HUPO Proteomics Standards Initiative (PSI), and develop reference implementations for these standards.